Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARO-DUX4

By Chris Wack Arrowhead Pharmaceuticals said Monday that it has filed an application in New Zealand to initiate a Phase 1/2 clinical trial of ARO-DUX4, its...

Related Keywords

New Zealand ,Chris Wack ,Standing Committee On Therapeutic Trials ,Devices Safety Authority ,Arrowhead Pharmaceuticals ,New Zealand Medicines ,Medical Devices Safety Authority ,Standing Committee ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Regulation Government Policy ,New Products Services ,Research Development ,Corporate Industrial News ,Products Services ,New Product Service Testing ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Arwr ,Us04280a1007 ,Regulation ,Government Policy ,New Products ,Services ,Research ,Development ,Corporate ,Industrial News ,Products ,New Product ,Service Testing ,Healthcare ,Life Sciences ,